Annan Yang
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 15
- Pancreatic and Hepatic Oncology Research 7
- Peptidase Inhibition and Analysis 3
- CAR-T cell therapy research 2
-
- Protein Degradation and Inhibitors 4
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 3
- Co-authors
- Alec C. Kimmelman (4 shared papers)Xiaoxu Wang (3 shared papers)Kwok‐Kin Wong (3 shared papers)Nathanael S. Gray (4 shared papers)N.V. Rajeshkumar (1 shared paper)Gerald C. Chu (1 shared paper)Shinichi Yabuuchi (1 shared paper)Daniel D. Von Hoff (1 shared paper)
- Journals
- Cancer Discovery (6 papers)Cell Reports (3 papers)Nature Chemical Biology (3 papers)Cancer Research (2 papers)Molecular Cell (2 papers)
- Partner nations
- United StatesChinaIsrael
In The Last Decade
Annan Yang
29 papers receiving 4.3k citations
Annan Yang's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 1.5k
- Cancer Research 802
- Molecular Biology 2.5k
- Physiology 142
- Pulmonary and Respiratory Medicine 707
Countries citing papers authored by Annan Yang
This map shows the geographic impact of Annan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annan Yang more than expected).
Fields of papers citing papers by Annan Yang
This network shows the impact of papers produced by Annan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annan Yang. The network helps show where Annan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Annan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The dTAG system for immediate and target-specific protein degradation Hit paper breakdown → | 2018 | 780 |
| 2 | CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation Hit paper breakdown → | 2017 | 619 |
| 3 | Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development Hit paper breakdown → | 2014 | 553 |
| 4 | Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations Hit paper breakdown → | 2014 | 408 |
| 5 | 2019 | 282 | |
| 6 | 2018 | 264 | |
| 7 | 2018 | 196 | |
| 8 | 2019 | 166 | |
| 9 | 2008 | 128 | |
| 10 | 2022 | 127 | |
| 11 | 2021 | 113 | |
| 12 | 2014 | 85 | |
| 13 | 2020 | 84 | |
| 14 | 2018 | 83 | |
| 15 | 2022 | 76 | |
| 16 | 2021 | 69 | |
| 17 | 2022 | 59 | |
| 18 | 2023 | 54 | |
| 19 | 2020 | 46 | |
| 20 | 2021 | 45 |
About Annan Yang
Annan Yang is a scholar working on Oncology, Molecular Biology, Cancer Research, Epidemiology and Cell Biology, having authored 30 papers that have together received 4.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Autophagy in Disease and Therapy (6 papers), Protein Degradation and Inhibitors (4 papers), Peptidase Inhibition and Analysis (3 papers), RNA modifications and cancer (3 papers), Down syndrome and intellectual disability research (3 papers), Ubiquitin and proteasome pathways (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (802 citations), Molecular Biology (2.5k citations), Physiology (142 citations) and Pulmonary and Respiratory Medicine (707 citations). Annan Yang has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Alec C. Kimmelman, Xiaoxu Wang, Kwok‐Kin Wong, Nathanael S. Gray, N.V. Rajeshkumar, Gerald C. Chu, Shinichi Yabuuchi, Daniel D. Von Hoff, Brian Michael Alexander and Anirban Maitra. Their work appears in journals such as Cancer Discovery, Cell Reports, Nature Chemical Biology, Cancer Research and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.